Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer-Reference-Cited by-同舟云学术

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer

Published:2012-06 Issue:3 Volume:76 Page:362-367
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Niho Seiji,Kunitoh Hideo,Nokihara Hiroshi,Horai Takeshi,Ichinose Yukito,Hida Toyoaki,Yamamoto Nobuyuki,Kawahara Masaaki,Shinkai Tetsu,Nakagawa Kazuhiko,Matsui Kaoru,Negoro Shunichi,Yokoyama Akira,Kudoh Shinzoh,Kiura Katsuyuki,Mori Kiyoshi,Okamoto Hiroaki,Sakai Hiroshi,Takeda Koji,Yokota Soichiro,Saijo Nagahiro,Fukuoka Masahiro

Funder

Chugai Pharmaceuticals

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference13 articles.

1. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006

2. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

3. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAiL;Reck;J Clin Oncol,2009

4. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

5. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer);Thatcher;Lancet,2005

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Biosimilar SCT510 Compared with Bevacizumab for the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study;Advances in Therapy;2024-09-04

2. A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL);Japanese Journal of Clinical Oncology;2024-04-09

3. Biosimilar in Lung Cancer;Biosimilars for Cancer Treatment;2024

4. Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung Cancer;JAMA Oncology;2023-12-21

5. Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from CheckMate 816;Cancer Science;2023-12-14